Genmab — Juli 2014
-
Det kender du nok selv svaret på.Der kan jo vente en pæn gevinst hvis alt går som planlagt, men hvis dara fejler på en eller anden måde så er din formue måske halveret på et splitsekund. Kan du leve med den risiko? jo man bør sprede risiko!
-
Har selv 56 % af min portefølje i Genmab, men jeg er også risikovillig.
-
Progressing an Antibody-Drug Conjugate Targeting Tissue Factor for the Treatment of Solid Cancers.Update on non-clinical safety & clinical development. http://adc-summit.com/agenda/day-2
-
Og Paul P. på forsiden...http://adc-summit.com/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind